Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4

Nicotinamide phosphoribosyltransferase (NAMPT), alongside being a crucial enzyme in NAD synthesis, has been shown to be a secreted protein (eNAMPT), whose levels are increased in patients affected by immune-mediated disorders. Accordingly, preclinical studies have highlighted that eNAMPT participates in the pathogenesis of several inflammatory diseases. Herein, we analyzed the effects of eNAMPT on macrophage-driven inflammation. RNAseq analysis of peritoneal macrophages (PECs) demonstrates that eNAMPT triggers an M1-skewed transcriptional program, and this effect is not dependent on the enzymatic activity. Noteworthy, both in PECs and in humanmonocyte-derivedmacrophages, eNAMPT selectively boosts IFN gamma-driven transcriptional activation via STAT1/3 phosphorylation. Importantly, the secretion of eNAMPT promotes the chemotactic recruitment of myeloid cells, therefore providing a potential positive feedback loop to foster inflammation. Last, we report that these events are independent of the activation of TLR4, the only eNAMPT receptor that has hitherto been recognized, prompting the knowledge that other receptors are involved.

Automated summary

This article investigates the effects of eNAMPT on macrophage-driven inflammation. The study finds that eNAMPT triggers an M1-skewed transcriptional program and selectively boosts IFN gamma-driven transcriptional activation via STAT1/3 phosphorylation. Furthermore, the secretion of eNAMPT promotes the chemotactic recruitment of myeloid cells, creating a positive feedback loop for inflammation. The research also reveals the involvement of receptors other than the recognized TLR4 receptor.